Biolife Solutions Reaches Analyst Target Price
June 01, 2018 at 07:36 AM EDT
In recent trading, shares of Biolife Solutions Inc (BLFS) have crossed above the average analyst 12-month target price of $10.67, changing hands for $10.71/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..